About

Yuliya Gevrenova is an associate in the Life Sciences Practice Group.

She advises clients across a wide range of regulatory, compliance and procedural issues in…

Yuliya Gevrenova is an associate in the Life Sciences Practice Group.

She advises clients across a wide range of regulatory, compliance and procedural issues in the food and pharmaceutical sectors, focusing on EU and Public International regulatory advice.

WIPO proposes new Patent Disclosure obligations on Genetic Resources: What impact for companies?

September 13, 2023

Pathogen Access and Benefit-Sharing (P-ABS) under the draft WHO Pandemic Treaty: Why Many Vaccine, Therapeutic, and Diagnostic Companies will be in Scope

July 12, 2023

Historic Marine Biodiversity Treaty creates new Access and Benefit-Sharing obligations for life sciences companies

June 21, 2023

EU Pharma Legislation Review Series: Decentralized Manufacturing

May 3, 2023

EU Pharma Legislation Review Series: Supply Security and Shortages Control

May 2, 2023

EU Pharma Legislation Review Series: GMO Medicines

April 28, 2023

EU Pharma Legislation Review Series: Addressing Environmental Risks

April 28, 2023

EU Pharma Legislation Review Series: AMR and Transferable Exclusivity Vouchers

April 28, 2023

Upcoming EU Rules on Green Claims

January 24, 2023

About

Yuliya Gevrenova is an associate in the Life Sciences Practice Group.

She advises clients across a wide range of regulatory, compliance and procedural issues in…

Yuliya Gevrenova is an associate in the Life Sciences Practice Group.

She advises clients across a wide range of regulatory, compliance and procedural issues in the food and pharmaceutical sectors, focusing on EU and Public International regulatory advice.

Connect:

Subscribe:

Blogs